Bank of New York Mellon’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-182,103
| Closed | -$1.06M | – | 4388 |
|
|
2019
Q1 | $1.06M | Buy |
182,103
+1,097
| +0.6% | +$3.74K | ﹤0.01% | 3131 |
|
|
2018
Q4 | $235K | Buy |
181,006
+48,478
| +37% | +$84.3K | ﹤0.01% | 3800 |
|
|
2018
Q3 | $457K | Buy |
132,528
+6,943
| +6% | +$26.1K | ﹤0.01% | 3688 |
|
|
2018
Q2 | $571K | Buy |
125,585
+1,507
| +1% | +$6K | ﹤0.01% | 3571 |
|
|
2018
Q1 | $409K | Buy |
124,078
+2,005
| +2% | +$7.1K | ﹤0.01% | 3672 |
|
|
2017
Q4 | $476K | Buy |
122,073
+49,464
| +68% | +$269K | ﹤0.01% | 3638 |
|
|
2017
Q3 | $751K | Sell |
72,609
-6,602
| -8% | -$65K | ﹤0.01% | 3380 |
|
|
2017
Q2 | $773K | Buy |
79,211
+17,563
| +28% | +$123K | ﹤0.01% | 3397 |
|
|
2017
Q1 | $419K | Sell |
61,648
-1,962
| -3% | -$11.3K | ﹤0.01% | 3627 |
|
|
2016
Q4 | $350K | Buy |
63,610
+5,770
| +10% | +$40.8K | ﹤0.01% | 3729 |
|
|
2016
Q3 | $439K | Sell |
57,840
-1,598
| -3% | -$11.7K | ﹤0.01% | 3605 |
|
|
2016
Q2 | $484K | Buy |
59,438
+5,348
| +10% | +$66.7K | ﹤0.01% | 3555 |
|
|
2016
Q1 | $704K | Sell |
54,090
-5,579
| -9% | -$64.4K | ﹤0.01% | 3267 |
|
|
2015
Q4 | $1.2M | Buy |
59,669
+21,428
| +56% | +$369K | ﹤0.01% | 3048 |
|
|
2015
Q3 | $467K | Sell |
38,241
-4,028
| -10% | -$75.5K | ﹤0.01% | 3610 |
|
|
2015
Q2 | $873K | Buy |
42,269
+19,570
| +86% | +$462K | ﹤0.01% | 3416 |
|
|
2015
Q1 | $479K | Buy |
22,699
+4,459
| +24% | +$116K | ﹤0.01% | 3625 |
|
|
2014
Q4 | $561K | Buy |
18,240
+5,176
| +40% | +$144K | ﹤0.01% | 3574 |
|
|
2014
Q3 | $231K | Buy |
+13,064
| New | +$165K | ﹤0.01% | 3858 |
|
Bank of New York Mellon's IMDZ Position: Q2 2019 in Review
Bank of New York Mellon sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 182,103 shares — an estimated $1.06M sold.
Bank of New York Mellon first reported a position in IMDZ in Q3 2014 and held it in 19 quarters. The position peaked at $1.2M in Q4 2015. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- Bank of New York Mellon reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- Bank of New York Mellon sold 182,103 Immune Design Corp. shares in Q2 2019, an estimated $1.06M.
- Bank of New York Mellon first reported a position in Immune Design Corp. in Q3 2014 and held it in 19 quarters.
- Bank of New York Mellon's Immune Design Corp. position peaked at $1.2M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on Bank of New York Mellon's 13F filing for Q2 2019, filed 12 Aug 2019.